Clinical trials
Phase 4 Hemophilia A trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Recruiting | 9 |
| Terminated | 8 |
| Unknown status | 6 |
| Active, not recruiting | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 8 |
| Baxalta now part of Shire | 7 |
| Pfizer | 6 |
| Swedish Orphan Biovitrum | 4 |
| Chulalongkorn University | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Grifols Biologicals, LLC | 2 |
| Octapharma | 2 |
| Sanofi | 2 |
| American Thrombosis and Hemostasis Network | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 67 |
| Hemophilia B | 5 |
| Blood Coagulation Disorders | 3 |
| Hematologic Diseases | 3 |
| Hemorrhage | 3 |
| Hemostatic Disorders | 3 |
| Coagulation Protein Disorders | 2 |
| Synovitis | 2 |
| von Willebrand Diseases | 2 |
| Blood Platelet Disorders | 1 |
Trials
Showing 51 to 67 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.